Tang X - Search Results

1

Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion.

Li Y, Cui Q, Liu S, Liu L, Li M, Gao J, Li Z, Cui W, Zhu X, Kang L, Yu L, Wu D, Tang X. Li Y, et al. Among authors: tang x. Cell Oncol (Dordr). 2024 Apr 25. doi: 10.1007/s13402-024-00945-7. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 38662336

2

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Cui Q, Qian C, Xu N, Kang L, Dai H, Cui W, Song B, Yin J, Li Z, Zhu X, Qu C, Liu T, Shen W, Zhu M, Yu L, Wu D, Tang X. Cui Q, et al. Among authors: tang x. J Hematol Oncol. 2021 May 25;14(1):82. doi: 10.1186/s13045-021-01092-4. J Hematol Oncol. 2021. PMID: 34034795 Free PMC article.

3

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

Tang X, Yang L, Li Z, Nalin AP, Dai H, Xu T, Yin J, You F, Zhu M, Shen W, Chen G, Zhu X, Wu D, Yu J. Tang X, et al. Am J Cancer Res. 2018 Jun 1;8(6):1083-1089. eCollection 2018. Am J Cancer Res. 2018. PMID: 30034945 Free PMC article.

4

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion.

Dai HP, Yin J, Li Z, Yang CX, Cao T, Chen P, Zong YH, Zhu MQ, Zhu XM, Xiao S, Wu DP, Tang XW. Dai HP, et al. Front Oncol. 2020 Mar 20;10:359. doi: 10.3389/fonc.2020.00359. eCollection 2020. Front Oncol. 2020. PMID: 32266142 Free PMC article.

5

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes.

Kang L, Tang X, Zhang J, Li M, Xu N, Qi W, Tan J, Lou X, Yu Z, Sun J, Wang Z, Dai H, Chen J, Lin G, Wu D, Yu L. Kang L, et al. Among authors: tang x. Exp Hematol Oncol. 2020 Jun 8;9:11. doi: 10.1186/s40164-020-00166-2. eCollection 2020. Exp Hematol Oncol. 2020. PMID: 32523801 Free PMC article.

6

Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations.

Qu C, Song Y, Yin J, Ma Y, Kang L, Li Z, Dai H, Zhu X, Yu L, Wu D, Tang X. Qu C, et al. Among authors: tang x. Bone Marrow Transplant. 2021 Jul;56(7):1710-1713. doi: 10.1038/s41409-021-01230-z. Epub 2021 Feb 24. Bone Marrow Transplant. 2021. PMID: 33627797 No abstract available.

7

Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.

Liu S, Cui Q, Dai H, Song B, Cui W, Xue S, Qiu H, Miao M, Jin Z, Li C, Fu C, Wang Y, Sun A, Chen S, Zhu X, Wu D, Tang X. Liu S, et al. Among authors: tang x. Transplant Cell Ther. 2021 Jun;27(6):481.e1-481.e7. doi: 10.1016/j.jtct.2021.02.032. Epub 2021 Feb 28. Transplant Cell Ther. 2021. PMID: 33785365 Free article.

8

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma.

Zhang Y, Li J, Lou X, Chen X, Yu Z, Kang L, Chen J, Zhou J, Zong X, Yang Z, Li M, Xu N, Jia S, Geng H, Chen G, Dai H, Tang X, Yu L, Wu D, Li C. Zhang Y, et al. Among authors: tang x. Front Oncol. 2021 May 25;11:664421. doi: 10.3389/fonc.2021.664421. eCollection 2021. Front Oncol. 2021. PMID: 34113569 Free PMC article.

9

MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation.

Zhang XY, Dai HP, Zhang L, Liu SN, Dai Y, Wu DP, Tang XW. Zhang XY, et al. Onco Targets Ther. 2021 Oct 29;14:5197-5204. doi: 10.2147/OTT.S324765. eCollection 2021. Onco Targets Ther. 2021. PMID: 34744437 Free PMC article.

10

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma.

Dai HP, Cui W, Cui QY, Zhu WJ, Meng HM, Zhu MQ, Zhu XM, Yang L, Wu DP, Tang XW. Dai HP, et al. Biomark Res. 2022 Feb 7;10(1):6. doi: 10.1186/s40364-022-00352-w. Biomark Res. 2022. PMID: 35130959 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,883 results

Search Page